2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- PMID: 30565953
- DOI: 10.1161/CIR.0000000000000624
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Erratum in
-
Correction to: 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.Circulation. 2019 Jun 18;139(25):e1178-e1181. doi: 10.1161/CIR.0000000000000699. Epub 2019 Jun 17. Circulation. 2019. PMID: 31206328 No abstract available.
Keywords: AHA Scientific Statements; Guidelines; biomarkers, coronary artery calcium score; cardiovascular disease; cholesterol, LDL-cholesterol; diabetes mellitus; drug therapy; ezetimibe; hydroxymethylglutaryl-CoA reductase inhibitors/statins; hypercholesterolemia; lipids; patient compliance; pharmacological; primary prevention; proprotein convertase subtilisin/kexin type 9 inhibitor (PCSK9) inhibitors; risk assessment; risk reduction discussion; risk treatment discussion, secondary prevention.
Similar articles
-
Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.Circulation. 2019 Jun 18;139(25):e1144-e1161. doi: 10.1161/CIR.0000000000000626. Epub 2018 Nov 10. Circulation. 2019. PMID: 30586775
-
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.Circulation. 2019 Jun 18;139(25):e1082-e1143. doi: 10.1161/CIR.0000000000000625. Epub 2018 Nov 10. Circulation. 2019. PMID: 30586774 Free PMC article.
-
Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.J Am Coll Cardiol. 2019 Jun 25;73(24):3210-3227. doi: 10.1016/j.jacc.2018.11.004. Epub 2018 Nov 10. J Am Coll Cardiol. 2019. PMID: 30423394
-
How Much Do Lipid Guidelines Help the Clinician? Reading Between the (Guide)lines.Methodist Debakey Cardiovasc J. 2019 Jan-Mar;15(1):16-22. doi: 10.14797/mdcj-15-1-16. Methodist Debakey Cardiovasc J. 2019. PMID: 31049145 Free PMC article. Review.
-
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.Hypertension. 2018 Jun;71(6):1269-1324. doi: 10.1161/HYP.0000000000000066. Epub 2017 Nov 13. Hypertension. 2018. PMID: 29133354 Review. No abstract available.
Cited by
-
Moderate-Intensity Statin Plus Ezetimibe: Time to Rethink it as an Optimal Initial Lipid-Lowering Strategy.Drugs. 2024 Nov 14. doi: 10.1007/s40265-024-02113-5. Online ahead of print. Drugs. 2024. PMID: 39542994 Review.
-
Role of intestinal testosterone-degrading bacteria and 3/17β-HSD in the pathogenesis of testosterone deficiency-induced hyperlipidemia in males.NPJ Biofilms Microbiomes. 2024 Nov 9;10(1):123. doi: 10.1038/s41522-024-00599-1. NPJ Biofilms Microbiomes. 2024. PMID: 39521773 Free PMC article.
-
Efficacy and diabetes risk of moderate-intensity statin plus ezetimibe versus high-intensity statin after percutaneous coronary intervention.Cardiovasc Diabetol. 2024 Nov 5;23(1):396. doi: 10.1186/s12933-024-02498-3. Cardiovasc Diabetol. 2024. PMID: 39501240 Free PMC article.
-
Proposing new lipoprotein (a) cut off value for Kazakhstan: pilot study.Front Cardiovasc Med. 2024 Oct 21;11:1468566. doi: 10.3389/fcvm.2024.1468566. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39498354 Free PMC article.
-
Causal effect of psoriasis on aortic valve stenosis: a two-sample Mendelian randomization study.J Geriatr Cardiol. 2024 Sep 28;21(9):865-873. doi: 10.26599/1671-5411.2024.09.002. J Geriatr Cardiol. 2024. PMID: 39483265 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
